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=Abstract  = We analysed 40 patients with soft tissue sarcomas (STS) of the 
extremities to investigate the prognostic significance of the growth fraction of the 
tumor. The patients consisted of 2 7  males and 13 females, and the ages ranged 
from 18 to 7 0  years (median 46.9 years). Tumors were located in the thigh (47. 
5%), forearm (15%), buttock ( lo%),  shoulder ( lo%),  axilla (5%), arm (5%), lower 
leg (5%), and foot (2.5%) in a descending order of frequency. Histologically, 
malignant fibrous histiocytoma (25%) and liposarcoma (25%) were the most 
common types, followed by synovial sarcoma (17.5%), malignant schwannoma 
( lo%) ,  and rhabdomyosarcoma (5%). Local recurrence ranging from 1 t o  4 times 
(average 1.7 times) was noted in 18 cases (45%). Distant metastasis was found in 
5 out of 30 patients (16.7%), and the lung, liver, and abdominal wall were the 
predilection sites. Cumulative survival rates of all STS studied were 76% and 
5 8 %  in 2 years and 5 years, respectively. Univariate analysis revealed that  
patient's age, surgical stage, histologic grade, differentiation of tumor cells, 
mitotic count, and proliferative index were related t o  survival. Among known 
parameters  of histologic grading, only mitotic count  was  correlated with 
proliferative index. Multivariate analysis showed that patient's age, surgical stage 
and proliferative index were significant prognostic factors. This study indicates 
that the proliferative index using the antibody against proliferating cell nuclear 
antigen is useful to assess the prognosis of STS. 
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l NTRODUCT l ON to estimate the prognosis of the patients, 
although it could be one of the important 
Soft tissue sarcomas (STS) comprise a prognostic factors. Major reasons for this might 
heterogeneous group of tumors and histologic be the relative rarity of STS, discrepancies in 
- --  p p  --- diagnosis and classif icat ion even among 
Kccclc.ccl I J I ~ L I , ~ I . \  1oC)!. . I I ICI  111 ~ I I ~ , I I  f( I ~ I I ~  \ ,IIK 11 I Y ) ~  experienced pathologists because of the 
A ]  S E g  6+J GI q-Eg 6+ $ 21 5+J$j : &'$++, -;j -?.% 
A ~ $ L ~ ~ L J  G ] i ? ] - t j q  9\i!plJ&J: ~ i : - ~ ~ ~  complex h~stology of STS, and the lack of a 
united view on the terminology (Tsujimoto et a/. 
1988). These recognitions have led a number of 
clinical investigators to propose the grade of 
malignancy as an important prognostic factor 
(Suit et a/. 1973; Russell et al. 1977; Markhede 
et al. 1982; Myhre-Jensen et al. 1983 & 1991 ; 
Costa et a/. 1984; Trojani et a/. 1984). However, it 
is difficult to define an universally accepted 
histologic grading system. Broders et a/. (1939) 
outlined the grade of STS by several histologic 
features including degree of cellularity, cellular 
pleomorphism or anaplasia, mitotic activity 
(frequency and abnormality of mitotic figures), 
degree of necrosis, and growth pattern 
(Enzinger and Weiss 1988). Although absolute 
criteria to determine an accurate prognosis of 
the patients with STS have not been established, 
the following factors have been suggested; 
cellularity, differentiation, pleomorphism, mitosis, 
and necrosis. Among them, mitosis and necrosis 
have been regarded as the most important 
parameters (Enzinger and Weiss 1988), and the 
reproducibil i ty of grading system showed 
relatively high agreement (Coindre etal. 1986). 
There has been a suggest ion that 
antibodies against proliferating cells such as Ki- 
67 might be  used for the purpose of the 
investigation of the cell proliferation, which might 
provide a more accurate estimate of 'the 
prognosis (Tsujimoto et al. 1988). Recently, a 
new antibody against proliferating cell nuclear 
antigen (PCNA) has been developed (Celis and 
Celis 1985; Robbins et al. 1987; Garcia et al. 
1989) and has proved to be useful in assessing 
the growth fraction of the tumor. We studied 40 
cases with STS of the extremities to investigate 
prognostic factors related to patient's survival 
and tested the usefulness of proliferative index 
using the antibody against PCNA. 
MATERIALS AND METHODS 
STS of the extremities were obtained from 
40 patients by surgical resection in the 
Department of Surgery, Seoul National University 
Hospital during the period from January 1980 to 
June 1991. We excluded STS arising from bone, 
internal organs, retroperitoneum, head and neck 
as well as the cases with inadequate clinical 
information, poor tissue preparat ion, and 
insufficient tissue sectioning. Clinical data 
including age, sex, location, size, stage, local 
recurrence, distant metastasis, and therapeutic 
modalities were obtained from the medical 
records and the cases have been followed up for 
more than 16 months. 
For the light microscopic examination, tissue 
samples were fixed in 10% formalin for 24 hours, 
processed routinely, and embedded in paraffin. 
Paraffin-embedded tissues were cut into 4 pm- 
thick sections and were stained with 
hematoxylin-eosin. We used the grading system 
proposed by Trojani et al .  in 1984, and 
summarize in Table 1. 
For the immunohistochemical study against 
PCNA, we used the monoclonal antibody, PCNA 
(DAKO) followed by avidin-biotin peroxidase 
complex method using Vectastain (Vector). 
Proliferative index (PI) was measured by the 
formula descr ibed below. The cells were 
counted in the best stained area at the h ~ g h  
power field ( x 400). 
Proliferative index (PI) 
- 
PCNA (+) tumor cell nuclei 
x loo(%) 
100 tumor cell nuclei 
Survival curves were determined from the 
time of the adequate surgery and were plotted 
using the Kaplan-Meier method. Then the log- 
Table 1. Grading system for the soft tlssue sarcoma 
(Trojan1 et a/. 1984) 
Score 0 1 2 3 
Differentlatlon Llke normal Certa~n Und~fferent~ated 
Mitos~s (I1 OHPF) 0-9 10-19 20- 
Necros~s No 4 0 %  50% 
Grade l 2-3 
Grade I I .  4-5 
Grade I l l  6-8 
rank test was used to evaluate the significance 
of individual factors using the PC-SAS software, 
6.04 version. The relation between the 
proliferative index and parameters of histologic 
grading was estimated by Kendall's tau B 
correlation coefficients. We used this method for 
the purpose of the analysis of collinearity before 
the multivariate analysis. .Multivariate analysis 
was taken by Weibull model. 
RESULTS 
The patients consisted of 27 males and 13 
females, and ages ranged from 18 to 70 years 
(median 46.9 year).  But the peak of age 
distribution was located in the fifth decade. 
Anatomical locations of STS were 77.5% in 
proximal and 22.5% in distal. Details were as 
follows; thigh (47.5%), forearm (15%), buttock 
( lo%),  shoulder ( lo%) ,  axilla (5%), arm (5%), 
lower leg (5%), and foot (2.5%j in a descending 
order of frequency. Maximal diameters of STS 
were mostly less than 10 c m  (72.5%).  
Proportions of patients' stages were 38.9% in 
stage 1, 22.2% in stage 2, 30.6% in stage 3 and 
8.3% in stage 4. Local recurrence ranging from 1 
to 4 times (average 1.7 times) was noted in 18 
cases (45%). Distant metastasis was found in 5 
out of 30 cases (16.7%), and the lung, liver and 
abdominal wall were the predilection sites. 
Detailed clinicar informarlon is described in a 
previous report (Chung et a/. submitted). 
Histologically, mal ignant fibrous 
histiocytoma (25%) and liposarcoma (25%) were 
the most common types, followed by synovial 
sarcoma (1 7.5%),  malignant schwannoma 
(1 Ox), rhabdomyosarcoma (5%) and others (1 7. 
5%). We divided STS into grade 1 (44.8%), grade 
1 1  (27.6%) and grade 1 1 1  (27.6%) by Trojani's 
grading system. But the parameters were 
reassessed for the statistical examination. 
Differentiation of tumor cells was divided into 
well djfferentjated group (62.0%) consisting of 
Trojani's score 1 and 2, and poorly differentiated 
group consisting of Trojani's score 3 (38.0%). 
Mitotic count of the tumor was divided into low 
mitotic count ( less than 101HPF) (62.0%) 
consisting of Trojani's score 1, and high mitotic 
count (equal to or more than 101HPF) (38.0%) 
consisting of Trojani's score 2 and 3. Extent of 
necrosis divided into absence of necrosis (72. 
4%), present but less than 50% necrosis (24. 
I%) ,  and present but equal to or more than 50% 
necrosis (3.5%). 
lmmunohistochemical stain against PCNA 
showed coarse granular reactivity in the nuclei 
(Fig. 1). Average proliferative index was 47% 
and we divided STS into high PI (equal to or 
more than 55%) (77.3%) and low PI (less than 
55%) (22.7%). 
Of the forty patients, twenty two patients 
have been alive, fifteen patients were dead, and 
three patients were losed during the clinical 
follow-up. Cumulative survival rates of all STS 
studied were 76% and 58% in 2 years and 5 
years, respectively. Univariate analysis of the 
survival curve revealed that the patient's age, 
surgical stage, histologic grade including 
differentiation of tumor cell and mitotic count, 
and proliferative index were of prognostic 
importance (Fig. 2). Other parameters such as 
local recurrence, sex, size, histologic diagnosis, 
and location d i d  not show any prognostic 
signif icance: Among known parameters of 
histologic grading,  only mitotic count was 
correlated with proliferative index by Kendall's 
tau B coefficients ( p  < 0.05) .  Multivariate 
regression analysis using the Weibull model 
showed that patient's age, surgical stage and 
proliferative index could be  independent 
prognostic factors (Table 2). 
D l  SCUSS l ON 
The role of the pathologist in the 
management of STS is in making a correct 
diagnosis and expressing the characteristics of 
the tumor in such a way that the management 
team has a clear understanding of its biological 
potential (Worth 1988). To evaluate the behavior 
of a STS, one needs to know the cell type, 
grade, mitotic count, size, depth and location. 
Fig. 1. lmmunohistochemical stain against PCNA shows coarse granular reactivity in the tumor cell nuclei with 
(A) high proliferative index (PI) and (B) low PI. 
Generally, mitotic count has been used for the cellularity and necrosis (Markhede et a/. 1982; 
evaluation of the patient's prognosis with or Myhre-Jensen et a/. 1983 & 1991; Costa et a/. 
without other factors such as differentiation, 1984; Trojani et a/. 1984). However variable 
Fig. 2. Survival curves of the patient's age (A), surgical stage (B), proliferative index(P1) (C) and histologic grade 
(D) including differentiation of tumor cell (E) and mitotic count (F). (A) 1. less than 30 year, 2. 30-39 year, 
3. 40-49 year, 4. 50-59 year, 5. more than 60 year. (p < 0.0005) (B) 1. stage 1, 2. stage 1 1 ,  3. stage 1 1 1 ,  4. 
stage IV. (p < 0.0005) (C) 1 .  P1<.55, 2. PI 2 55. (p < 0.01) (D) 1. grade 1 ,  2. grade 1 1 ,  3. grade Ill. (p < 0. 
05) (E) I. well differentiated, 2. poorly differentiated. (p < 0.05) (F) I. mitotic count < IOIHPF, 2. mitotic 
count 2 IOIHPF. (p < 0.05) 
HPF: high power field ( x 400) 
Table 2. Multivariate analysis of the prognostic 
factors 
Prognostic factors Estimate Standard error p-value 
-- -- -- - - -- 
Proliferative index -1.126 0.255 <0.0005 
Stage -0.626 0.150 <0.0005 
Age 0.274 0.097 <0.005 
Grade 0.094 0.289 NS 
Scale 
counting methods, delay in the fixation of the 
tumor, limitation of adequate sampling of the 
tumor and different optical equipment were all 
obstacles in obtaining a reliable result. Some 
investigators suggested that mitotic index, i.e., 
the number of mitotic figures with reference to 
the number of nuclei, would probably be a better 
measure (Myhre-Jensen et a / .  1991). 
Furthermore, Ueda et a/ .  (1  989) reported that 
immunohistochemical staining against Ki-67 
ant~gen, a proliferating cell marker, would be of 
NS : not significant prognostic significance. Current study using the 
antibody against PCNA showed close correlation 
between the patient's survival and proliferative 
index. Furthermore it would be an independent 
prognostic factor separated from other 
parameters such as stage and grade. i h e  result 
of the staining method against PCNA is easy to 
read because of its distinct nuclear staining. 
Although delayed fixation would produce a less 
sensitive result, its influence might be negligible. 
It is certain that the proliferative index using the 
antibody aginst PCNA would be a useful 
prognostic factor. Nevertheless the estimate of a 
patient's prognosis must be made considering 
all prognostic parameters. 
Conventionally, the histologic diagnosis, size 
and location of the tumor resulting in the 
limitation of surgery, and necrosis have been 
known to be prognostic factors. Although our 
results could not confirm their usefulness, this 
might be due to the relative small numbers of 
patients. And the modification of the parameters 
for the grading system was also due to the 
above reason. It has been known that grading of 
STS must be essential to predict the patient's 
prognosis. Among the variable criteria for 
grading, we accepted Trojani's grading system 
which provides objectivity, simplicity and 
reproducibility. 
In conclusion, we propose a proliferative 
index using the antibody against PCNA as a 
useful prognostic factor and discussed the 
grading system for STS with a suggestion that 
Trojani's grading system would be a simple, 
objective and reproducible method. 
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